izpis_h1_title_alt

In silico profiling of endocrine-disrupting potential of bisphenol analogues and their halogenated transformation products
ID Nowak, Karolina (Avtor), ID Jakopin, Žiga (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,32 MB)
MD5: 101F4E8A2749F7BED55A4F9AB1D25346
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S027869152300025X Povezava se odpre v novem oknu

Izvleček
Due to its endocrine-disrupting properties, bisphenol A (BPA) is being phased out from plastics, thermal paper and epoxy resins, and its replacements are being introduced into the market. Bisphenols are released into the environment, where they can undergo halogenation. Unlike BPA, the endocrine-disrupting potential of BPA analogues and their halogenated transformation products has not been extensively studied. The aim of this study was to evaluate the endocrine-disrupting potential of 18 BPA analogues and their halogenated derivatives by calculating affinities for 14 human nuclear receptors utilizing the Endocrine Disruptome and VirtualToxLab™ in silico tools. Our simulations identified AR, ERs, and GR as the most favorable targets of bisphenols and their derivatives. Several BPA analogues displayed a higher predicted potential for endocrine disruption than BPA. Our models highlighted BPZ and BPPH as the most hazardous in terms of predicted endocrine activities. Halogenation, in general, was predicted to increase the binding affinity of bisphenols for AR, ERβ, MR, GR, PPARγ, and TRβ. Notably, mono- or 2,2′-di-halogenated bisphenols exhibited the highest potential for endocrine disruption. In vitro corroboration of the obtained results should be the next milestone in evaluating the safety of BPA substitutes and their halogenated transformation products.

Jezik:Angleški jezik
Ključne besede:BPA, BPA analogues, halogenated bisphenols, nuclear receptors, endocrine disruption, in silico
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:12 str.
Številčenje:Vol. 173, art. 113623
PID:20.500.12556/RUL-148309-8d21348f-c78d-ef65-1ed3-d25bfffe1452 Povezava se odpre v novem oknu
UDK:612.43:620.266.1
ISSN pri članku:1873-6351
DOI:10.1016/j.fct.2023.113623 Povezava se odpre v novem oknu
COBISS.SI-ID:138155779 Povezava se odpre v novem oknu
Datum objave v RUL:11.08.2023
Število ogledov:522
Število prenosov:31
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Food and chemical toxicology
Založnik:Elsevier
ISSN:1873-6351
COBISS.SI-ID:4308780 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:BPA analogi, halogenirani bisfenoli, nuklearni receptorji, endokrine motnje, in silico, endokrinologija

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0420
Naslov:Napredna imunološka zdravila in celični pristopi v farmaciji

Financer:Drugi - Drug financer ali več financerjev
Program financ.:European Federation of Immunological Societies-Immunology Letters, Short-Term Fellowship

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj